Uniform Overexpression and Rapid Accessibility of α5β1 Integrin on Blood Vessels in Tumors

Author:

Parsons-Wingerter Patricia,Kasman Ian M.,Norberg Scott,Magnussen Anette,Zanivan Sara,Rissone Alberto,Baluk Peter,Favre Cecile J.,Jeffry Ursula,Murray Richard,McDonald Donald M.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference58 articles.

1. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer;Yang;N Engl J Med,2003

2. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004

3. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody;Yuan;Proc Natl Acad Sci USA,1996

4. Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis;Shaheen;Cancer Res,1999

5. Regression of established tumors and metastases by potent vascular endothelial growth factor blockade;Huang;Proc Natl Acad Sci USA,2003

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3